Abbott Integrates its CGM Technology with Tandem's Insulin Delivery System for Improving Diabetes Management
Shots:
- The companies collaborated to develop & commercialize integrated diabetes solutions that combine Abbott's FreeStyle Libre CGM technology with Tandem's t:slim X2 pump to improve diabetes management
- In Oct’2019- the two companies collaborated to their technologies for monitoring glucose without fingersticks while the current agreement covers the technical development of device integration and its commercial activities
- The companies initially commercialize the integrated solution in the US and Canada and may expand it to other countries in the future
Click here to read full press release/ article | Ref: Abbott | Image: Abbott
Related News: Abbott and Tandem Collaborate to Explore Integrated Diabetes Solutions Improving Diabetes Management
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com
